Pure Global
NCT06038604

Glioblastoma Psychosocial Support Program

Psychosocial Support Program for Patients With Glioblastoma and Their Family Caregivers
Duke University·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Glioblastoma
Drug/Device/Intervention
Psychosocial Support Intervention
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Duke University
Location
Durham, United States of America
Timeline & enrollment
Phase
N/A
Start date
Nov 03, 2023
End date
Apr 01, 2024
Enrollment
40 participants
Primary outcome

Number of participants who complete study participation,Number of participants who complete post-intervention assessment,Participants' satisfaction with treatment

Summary

The goal of the study is to conduct a pilot test of the psychosocial support intervention
 with family caregivers and/or patients coping with glioblastoma.

ICD-10 classifications
Malignant neoplasm of brainMalignant neoplasm: Brain, unspecifiedMesotheliomaMalignant neoplasm: Brain stemMalignant neoplasm: Overlapping lesion of brain
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06038604
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06038604 through Pure Global AI's free database. This phase not specified trial is sponsored by Duke University and is currently Recruiting. The study focuses on Glioblastoma. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.